Why the study?
Do low and high dose infusions of glyceryl trinitrate reduce myocardial ischaemia in patients with coronary heart disease?
Population
10 patients with coronary heart disease
Comparison
Glyceryl trinitrate (low and high dose infusions) vs Baseline
Design
Other
Authors
Loading...
High-dose glyceryl trinitrate adds no anti-ischaemic benefit over low-dose; leaves optimal dosing and perfusion effects open in coronary disease.
Do low and high dose infusions of glyceryl trinitrate reduce myocardial ischaemia in patients with coronary heart disease?
High-dose glyceryl trinitrate does not provide additional anti-ischaemic benefit over low-dose due to a fall in transmural perfusion gradient, though it does not worsen ischaemia.
Ihlen et al. (1984) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: